Erik Emerson
Förmögenhet: 241 722 $ per 2026-10-31
Förmögenhet: 241 722 $ per 2026-10-31
Mr. Erik Emerson is a Chief Executive Officer & Director at GlucoTrack, Inc. and a Chief Executive Officer & Director at Lokahi Therapeutics, Inc. He is on the Board of Directors at GlucoTrack, Inc. and Lokahi Therapeutics, Inc. Mr. Emerson was previously employed as a President & Director by Apimeds Pharmaceuticals US, Inc., a Chief Commercial Officer by Odyssey Health, Inc., a Chief Commercial Officer by Mezzion Pharmaceuticals, Inc., a President & Chief Executive Officer by Symplmed Pharmaceuticals LLC, a Senior Director-Commercial Development by XOMA Corp., and a Marketing Director by Gilead Sciences, Inc. He also served on the board at Adhera Therapeutics, Inc. He received his undergraduate degree from the University of Oregon.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
4,97 % | 2025-10-15 | 75 000 ( 4,97 % ) | 225 750 $ | 2026-10-31 |
GLUCOTRACK INC 1,67 % | 2026-08-10 | 19 719 ( 1,67 % ) | 15 972 $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| GLUCOTRACK, INC. | Verkställande Direktör | 2026-07-14 |
| Företag | Position | Slut |
|---|---|---|
| ODYSSEY HEALTH, INC. | Företagsledare/Principal | 2023-10-01 |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Företagsledare/Principal | 2020-01-01 |
| ADHERA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2019-12-19 |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkställande Direktör | 2018-05-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
GlucoTrack, Inc.
GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Odyssey Health, Inc.
Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån